Catheter Precision Inc.
VTAK
Get informed when a big investor buys or sells
+ FollowMarket Cap$471.18K
Close$
$-0.10
165.5% downside
Current Fair Value
165.5% downsideOvervalued by 165.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $471,183.00 |
|---|---|
| Enterprise Value | $11.80 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-15.9 |
| Beta | 0.47 |
| Outstanding Shares | 2,767,440,000 |
Return
| Return on Equity | -75.60% |
|---|---|
| Return on Assets | -36.01% |
| Return on Invested Capital | -86.91% |
Valuation & Multiples
| P/E Ratio | -0.02 |
|---|---|
| PEG | 0.04 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 8.44 |
| Enterprise Value to EBIT | -0.58 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.01 |
| Debt to Equity | 0.68 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$-19.00
Average shareholder expectationRevenue Estimate
$2.00 M
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-13.30
Average shareholder expectationRevenue Estimate
$2.80 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 0.00% |
|---|---|
| Total Invested | $57,231▼ 44.40% |
| Investors Holding | 10▼ 2.00% |
ESG Score
No data
About Catheter Precision Inc.
74 employeesadvanced excimer laser-based vascular and dermatological therapies we are a commercial-stage medical device company leveraging our advanced excimer laser-based platform for use in the treatment of vascular and dermatological diseases. we...